Literature DB >> 31057177

Clinical management of an adult with erythema infectiosum: a retrospective case report.

David Gryfe1, Calvin Wong2.   

Abstract

OBJECTIVE: To review the epidemiology, etiology, diagnosis and typical management of erythema infectiosum and to illustrate the clinical management of an adult with erythema infectiosum. CLINICAL FEATURES: A 38-year-old male complaining of severe global pain, swelling, weakness and stiffness in his shoulders, elbows, knees, and fingers of seven weeks duration. INTERVENTION AND OUTCOME: The patient was treated with a combination of 1) pharmacological treatment of naprosyn, prednisone, methotrexate, hydroquinone and sulfasalazine, 2) conservative treatment consisting of spinal manipulation, peripheral joint mobilization, acupuncture and low-tech Qi Gong and Tai Chi exercises, and 3) an active physiotherapy program consisting of strengthening exercises, and stationary bike. The patient reported marked improvement in pain, mobility, strength, and function with the addition of conservative physical treatment.
SUMMARY: Erythema infectiosum is associated with a wide spectrum of clinical manifestations, where arthropathy is the most common clinical manifestation in adults. Erythema infectiosum should be suspected as a potential differential diagnosis when a patient presents with red or purplish skin rashes, especially when accompanied by fever and joint pain. Conservative management could be considered as an adjunctive therapy option for this condition. However, further validation and research is warranted.

Entities:  

Keywords:  Parvovirus B19; arthropathy; chiropractic; erythema infectiosum; physiotherapy

Year:  2019        PMID: 31057177      PMCID: PMC6493208     

Source DB:  PubMed          Journal:  J Can Chiropr Assoc        ISSN: 0008-3194


  22 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Acupuncture for osteoarthritic pain: an observational study in routine care.

Authors:  K Linde; W Weidenhammer; A Streng; A Hoppe; D Melchart
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

3.  The effectiveness of thoracic spine manipulation for the management of musculoskeletal conditions: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Ronald F Walser; Brent B Meserve; Thomas R Boucher
Journal:  J Man Manip Ther       Date:  2009

4.  Infection and immunity for human parvovirus B19 in patients with febrile exanthema.

Authors:  M S Pedranti; P Barbero; C Wolff; L M Ghietto; M Zapata; M P Adamo
Journal:  Epidemiol Infect       Date:  2011-05-18       Impact factor: 2.451

Review 5.  A comprehensive review of health benefits of qigong and tai chi.

Authors:  Roger Jahnke; Linda Larkey; Carol Rogers; Jennifer Etnier; Fang Lin
Journal:  Am J Health Promot       Date:  2010 Jul-Aug

Review 6.  Parvovirus-associated arthritis.

Authors:  T L Moore
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

7.  A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists.

Authors:  Susan M Lowry; Lawrence H Brent; Stephen Menaldino; Jonathan R Kerr
Journal:  Clin Infect Dis       Date:  2005-07-14       Impact factor: 9.079

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection.

Authors:  Eiichi Ogawa; Shigeru Otaguro; Masayuki Murata; Mosaburo Kainuma; Yasunori Sawayama; Norihiro Furusyo; Jun Hayashi
Journal:  J Infect Chemother       Date:  2008-10-21       Impact factor: 2.211

10.  Persistent parvovirus B19 infection and arthralgia in a patient mistakenly treated for Lyme disease.

Authors:  Marinko Dobec; Franz Kaeppeli; Pascal Cassinotti; Norbert Satz
Journal:  J Clin Virol       Date:  2008-07-23       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.